GlassScriptPhysician profile
Terrill D Hulson
NPI 1639136542
$1,933.26
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,756 · 2020: $107 · 2021: $14.55 · 2022: $32.71 · 2023: $23.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $23.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $23.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.33 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $240.35 | 2019 | |
| Novo Nordisk INC | $209.27 | 2019-2020 | |
| Amarin Pharma, INC. | $185.12 | 2019 | |
| Glaxosmithkline, LLC. | $158.58 | 2019 | |
| Vifor Pharma, INC. | $119.69 | 2019 | |
| Amgen INC. | $117.77 | 2019 | |
| Novartis Pharmaceuticals Corporation | $109.60 | 2019 | |
| Shire North American Group INC | $97.23 | 2019 | |
| Abbvie INC. | $85.60 | 2019-2023 | |
| Pfizer INC. | $72.95 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $58.65 | 2019-2020 | |
| Astellas Pharma US INC | $45.57 | 2019 | |
| Janssen Pharmaceuticals, INC | $43.90 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $30.45 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $23.76 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $23.18 | 2019 | |
| Merck Sharp & Dohme LLC | $12.71 | 2019 | |
| Lilly USA, LLC | $11.76 | 2019 | |
| Aytu Biopharma, INC. | $10.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Terrill Hulson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.